Infinity Pharmaceuticals, Inc. Repayments of Notes Payable
Infinity Pharmaceuticals, Inc. reported Repayments of Notes Payable of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2020-03-03
- Infinity Pharmaceuticals, Inc. repayments of notes payable for the quarter ending 2019-12-31 was $0.00.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for the quarter ending 2019-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for the quarter ending 2018-12-31 was $0.00.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for the quarter ending 2018-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for fiscal 2018 was $4.00M.
- Infinity Pharmaceuticals, Inc. repayments of notes payable for fiscal 2017 was $0.00.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $0.00 10-K · filed 2020-03-03 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-07-30 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $4.00M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $4.00M 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | $4.00M 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |